Enacted in 2013, Texas’s House Bill 2 (HB 2) was one of the most restrictive abortion laws in the country. The law had 4 provisions: (1) physicians providing abortion had to have admitting privileges at nearby hospitals, (2) medication abortion had to be provided according to the protocol described in the US Food and Drug Administration (FDA)-approved labeling of mifepristone, (3) most abortions at 20 weeks postfertilization or later were banned, and (4) facilities providing abortion had to meet the standards of ambulatory surgical centers. The first 3 provisions went into effect by November 2013; the fourth provision, meeting the standards of ambulatory surgical centers, was enforced only briefly in October 2014 before the US Supreme Court issued a stay.
Grossman D. The Use of Public Health Evidence in Whole Woman’s Health v Hellerstedt. JAMA Intern Med. 2017;177(2):155–156. doi:10.1001/jamainternmed.2016.6839
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.